SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-037386
Filing Date
2022-11-10
Accepted
2022-11-10 16:13:20
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pstx-8k_20221110.htm   iXBRL 8-K 41375
2 EX-99.1 pstx-ex991_6.htm EX-99.1 198168
3 GRAPHIC gst4nx4hmhkl000001.jpg GRAPHIC 752068
  Complete submission text file 0001564590-22-037386.txt   1397546

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstx-20221110.xsd EX-101.SCH 5569
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20221110_lab.xml EX-101.LAB 20063
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20221110_pre.xml EX-101.PRE 11919
8 EXTRACTED XBRL INSTANCE DOCUMENT pstx-8k_20221110_htm.xml XML 3693
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39376 | Film No.: 221377319
SIC: 2836 Biological Products, (No Diagnostic Substances)